The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
| dc.contributor.author | Muzaffar, Mahvish | |
| dc.contributor.author | Navaid, Musharraf | |
| dc.contributor.author | Naqash, Abdul Rafeh | |
| dc.date.accessioned | 2022-11-09T16:32:49Z | |
| dc.date.available | 2022-11-09T16:32:49Z | |
| dc.date.issued | 2022 | |
| dc.identifier.doi | 10.3390/cancers14010186 | |
| dc.identifier.issn | 2072-6694 | |
| dc.identifier.uri | http://hdl.handle.net/10342/11729 | |
| dc.language.iso | en_US | en_US |
| dc.subject | hepatocellular carcinoma | en_US |
| dc.subject | inflammatory biomarkers | en_US |
| dc.subject | neutrophil-lymphocyte ratio | en_US |
| dc.title | The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma | en_US |
| dc.type | Article | en_US |
| ecu.journal.issue | 1 | en_US |
| ecu.journal.name | Cancers | en_US |
| ecu.journal.volume | 14 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- MuzaffarTheSystemicInflammatoryResponseIdentifiesPatientswithAdverseClinicalOutcome.pdf
- Size:
- 3.01 MB
- Format:
- Adobe Portable Document Format
- Description: